Literature DB >> 18765078

Anemia and the potential role of erythropoiesis-stimulating agents in heart failure.

Haroon A Faraz, Syed F Zafar, Jalal K Ghali.   

Abstract

The recognition of the high prevalence and the independent prognostic role of anemia in heart failure (HF) has contributed to intensification of the search for an effective treatment. A central role of erythropoietin in cardiorenal anemia syndrome has been proposed. Several clinical trials have established the safety and efficacy of erythropoiesis-stimulating agents in correcting anemia in patients with HF. The recognition of the pleiotropic effect of erythropoietin has expanded targets of therapy. The ongoing outcomes trial with darbepoetin alfa will determine the role of this novel therapy in the treatment of HF.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18765078     DOI： 10.1007/s11897-008-0014-0

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN： 1546-9530


  61 in total

1.  Intravenous iron alone for the treatment of anemia in patients with chronic heart failure.

Authors:  Aidan P Bolger; Frederick R Bartlett; Helen S Penston; Justin O'Leary; Noel Pollock; Raffi Kaprielian; Callum M Chapman
Journal:  J Am Coll Cardiol       Date:  2006-08-28       Impact factor: 24.094

2.  Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.

Authors:  Alan S Go; Jingrong Yang; Lynn M Ackerson; Krista Lepper; Sean Robbins; Barry M Massie; Michael G Shlipak
Journal:  Circulation       Date:  2006-06-05       Impact factor: 29.690

Review 3.  Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options.

Authors:  Yi-Da Tang; Stuart D Katz
Journal:  Circulation       Date:  2006-05-23       Impact factor: 29.690

Review 4.  Erythropoietin after a century of research: younger than ever.

Authors:  Wolfgang Jelkmann
Journal:  Eur J Haematol       Date:  2007-01-23       Impact factor: 2.997

Review 5.  Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors.

Authors:  Kim E Jie; Marianne C Verhaar; Maarten-Jan M Cramer; Karien van der Putten; Carlo A J M Gaillard; Pieter A Doevendans; Hein A Koomans; Jaap A Joles; Branko Braam
Journal:  Am J Physiol Renal Physiol       Date:  2006-08-01

6.  Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization.

Authors:  B Daan Westenbrink; Erik Lipsic; Peter van der Meer; Pim van der Harst; Hisko Oeseburg; Gideon J Du Marchie Sarvaas; Johan Koster; Adriaan A Voors; Dirk J van Veldhuisen; Wiek H van Gilst; Regien G Schoemaker
Journal:  Eur Heart J       Date:  2007-06-17       Impact factor: 29.983

Review 7.  Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure.

Authors:  Karien van der Putten; Branko Braam; Kim E Jie; Carlo A J M Gaillard
Journal:  Nat Clin Pract Nephrol       Date:  2008-01

8.  Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry).

Authors:  James B Young; William T Abraham; Nancy M Albert; Wendy Gattis Stough; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Lilin She; Jie Lena Sun; Clyde W Yancy; Gregg C Fonarow
Journal:  Am J Cardiol       Date:  2008-01-15       Impact factor: 2.778

9.  Anaemia and renal dysfunction are independently associated with BNP and NT-proBNP levels in patients with heart failure.

Authors:  Jochem Hogenhuis; Adriaan A Voors; Tiny Jaarsma; Arno W Hoes; Hans L Hillege; Johannes A Kragten; Dirk J van Veldhuisen
Journal:  Eur J Heart Fail       Date:  2007-05-25       Impact factor: 15.534

10.  Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia.

Authors:  Jalal K Ghali; Inder S Anand; William T Abraham; Gregg C Fonarow; Barry Greenberg; Henry Krum; Barry M Massie; Scott M Wasserman; Marie-Louise Trotman; Yan Sun; Beat Knusel; Paul Armstrong
Journal:  Circulation       Date:  2008-01-14       Impact factor: 29.690
View more
  1 in total

Review 1.  Can Iron Play a Crucial Role in Maintaining Cardiovascular Health in the 21st Century?

Authors:  Michał Szklarz; Katarzyna Gontarz-Nowak; Wojciech Matuszewski; Elżbieta Bandurska-Stankiewicz
Journal:  Int J Environ Res Public Health       Date:  2022-09-22       Impact factor: 4.614
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.